The first completed genome of species Prevotella bivia, assembled from a clinically derived strain PLW0727.

Clinically derived Completed genome Hybrid assembly Prevotella bivia Two chromosomes

Journal

Journal of global antimicrobial resistance
ISSN: 2213-7173
Titre abrégé: J Glob Antimicrob Resist
Pays: Netherlands
ID NLM: 101622459

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 01 06 2023
revised: 14 09 2023
accepted: 15 10 2023
medline: 4 12 2023
pubmed: 23 10 2023
entrez: 22 10 2023
Statut: ppublish

Résumé

Prevotella bivia is a species that commonly colonizes various human body sites, and it is associated with lots of human infections. However, until now, no complete genome sequence of this species has been published. Here, we assembled the first complete genome of P. bivia from a clinically derived strain PLW0727, to characterize its general genomic features, and to profile the capacity in encoding antibiotic resistance and virulence factors. Whole-genome sequencing was performed using Illumina and Nanopore platforms. Hybrid assembly was conducted using flye v2.9.1 and Unicycler v0.4.9b. Assembly completeness was assessed using CheckM v1.0.12. Comprehensive genome annotation was performed using eggNOG-mapper v2.1.5 and PATRIC v3.6.10. The complete genome of PLW0727 consists of two circular chromosomes, chr1 and chr2, exhibiting a completeness of 99.66%, a G+C content of 39.5%, and a total size of 2.43 Mb. Chr1 and chr2 have lengths of 1 272 652 bp and 1 155 021 bp, harbouring 1 132 CDSs and 1 055 CDSs, respectively. Completion of the genome significantly reduced the proportion of hypothetical CDS annotations compared with the draft genomes. A gene-encoding antibiotic resistance to beta-lactams (i.e., cfxA3) has been annotated in chr2. By providing the genome sequence, strain PLW0727 was identified as a human pathogen with a probability of 0.614 using the PathogenFinder. Furthermore, genes involved in virulence-related functions, including host cell adherence and capsule immune modulation were also annotated. This study assembles the first complete genome for P. bivia, providing valuable genomic insights into its phylogeny, pathogenicity, and antibiotic resistance. These findings have important implications for the clinical management and prevention of P. bivia infections.

Identifiants

pubmed: 37866682
pii: S2213-7165(23)00178-9
doi: 10.1016/j.jgar.2023.10.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

268-270

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Yao Peng (Y)

Department of Gastroenterology and Hepatology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Xunchao Cai (X)

Department of Gastroenterology and Hepatology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Meng Li (M)

Department of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Li Deng (L)

Department of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Yuhan Wang (Y)

Department of Urology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Yifeng Qiu (Y)

Department of Urology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Longyan Zhao (L)

Department of Urology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Yue Xiao (Y)

Department of Outpatient, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.

Long Xu (L)

Department of Gastroenterology and Hepatology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China. Electronic address: longxu1012@szu.edu.cn.

Qi Hou (Q)

Department of Urology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China; International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen, China. Electronic address: qi_hou@foxmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH